Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
Purpose: Proton pump inhibitor (PPI) drugs are approved for the management of gastric acid–related diseases, mainly treatment of gastroesophageal reflux disease, treatment of nonsteroidal anti-inflammatory drugs (NSAID)–related gastrointestinal complications and prevention in at-risk patients, Helic...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 76; no. 3; pp. 449 - 458 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Mar2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |